Steven Ryder is a director of Reata Pharmaceuticals Inc.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Feb 24 | RLYB Rallybio | Option Common Stock | Grant | Acquire A | No | No | 1.86 | 120,000 | 223.20 k | 120,000 |
26 Sep 23 | RETA Reata Pharmaceuticals | Class A common stock | Sale back to company | Dispose D | No | No | 0 | 10,907 | 0.00 | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 93.61 | 2,137 | 200.04 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 93.61 | 441 | 41.28 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 32.36 | 5,492 | 177.72 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 32.36 | 6,038 | 195.39 k | 0 |
26 Sep 23 | RETA Reata Pharmaceuticals | Stock Option Class A common stock | Sale back to company | Dispose D | No | No | 32.36 | 1,322 | 42.78 k | 0 |
7 Jun 23 | RETA Reata Pharmaceuticals | Class A common stock | Grant | Acquire A | No | No | 93.61 | 1,682 | 157.45 k | 10,907 |
7 Jun 23 | RETA Reata Pharmaceuticals | Class A common stock | Grant | Acquire A | No | No | 93.61 | 347 | 32.48 k | 9,225 |
7 Jun 23 | RETA Reata Pharmaceuticals | Stock Option (right-to-buy) Class A common stock | Grant | Acquire A | No | No | 93.61 | 2,137 | 200.04 k | 2,137 |